[
adar poonawalla
]
Please be patient: SII’s Poonawalla asks nations waiting for Covishield supplies
By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON FEB 21, 2021 12:03 PM IST
- Till February 8, India has exported Covid-19 vaccines worth ₹338 crore, Union minister Piyush Goyal had informed Parliament during the Budget Session earlier this month.

‘I’m on it’: SII’s Adar Poonawalla assures Covid-19 vaccine supply to Canada
By hindustantimes.com | Written by Srivatsan K C, Hindustan Times, New Delhi
UPDATED ON FEB 15, 2021 02:44 PM IST
Prime Minister Narendra Modi had assured Covid-19 vaccine supplies sought by Canada in a call with PM Trudeau.

'Rapid pace of vaccination,' tweets Adar Poonawalla after visiting Pune centre
By hindustantimes.com | Edited by Poulomi Ghosh
UPDATED ON FEB 13, 2021 01:35 PM IST
'What an excellent setup,' Poonawalla said as he praised health ministry's arrangement of vaccine roll-out in the country.

Anand Mahindra’s share regarding Covid vaccine is a hit among netizens
By Srimoyee Chowdhury
UPDATED ON FEB 12, 2021 01:02 AM IST
Thinking about what to gift your loved one on Valentine's Day? Anand Mahindra has the answer.

Adar Poonawalla to buy Magma Fincorp. Here’s all about the deal
By hindustantimes.com | Written by Meenakshi Ray
PUBLISHED ON FEB 11, 2021 07:53 PM IST
The Pune-based Poonawalla Group has said it is acquiring a controlling 60 per cent stake in Magma Fincorp by subscribing to a ₹3,456-crore preferential issue.

Vaccine billionaire Adar Poonawalla's buyout of Indian shadow bank boosts stock
Bloomberg
PUBLISHED ON FEB 11, 2021 07:33 PM IST
Adar Poonawalla is expanding his shadow banking business just as the industry is showing signs of recovery following a crisis that started with the collapse of a non-bank financier in 2018. The pandemic had made it harder for small shadow lenders such as Magma Fincorp to raise money.

UK delegation visits Serum institute, talks held on enhancing relationship
By hindustantimes.com | Edited by Ayshee Bhaduri, Hindustan Times, New Delhi
PUBLISHED ON FEB 08, 2021 05:09 PM IST
- Elizabeth Truss is on a four-day visit to India for talks with Piyush Goyal towards an “enhanced trade partnership”. After concluding her visit to the facility at Pune, Truss tweeted that SII will also be producing 1.3 billion doses for the COVAX alliance to which UK has committed £548 million.

SII to supply 1.1 billion doses of Covid-19 vaccines to Covax vaccine scheme
Reuters, Geneva/london
PUBLISHED ON FEB 03, 2021 07:45 PM IST
UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

Industry captains welcome hike in public spending
By Ishita Guha
PUBLISHED ON FEB 02, 2021 12:33 AM IST
“The government, through the budget, has clearly indicated that it is willing to spend to stimulate growth even if it means higher fiscal deficit,” said Uday Kotak, executive vice chairman and managing director of Kotak Mahindra Bank Ltd.

Now, SII seeks trial approval for Novavax Covid vaccine
By Rhythma Kaul, New Delhi
PUBLISHED ON JAN 31, 2021 04:14 AM IST
SII is currently manufacturing Covishield, which has been developed by the University of Oxford and AstraZeneca and is one of the two coronavirus vaccines approved in the country.

News updates from HT: SII hopeful of launching Covavax by June 2021
By hindustantimes.com, Hindustan Times, New Delhi
PUBLISHED ON JAN 30, 2021 04:51 PM IST
- Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.

News updates from HT: IRCTC to resume e-catering services from Feb
By hindustantimes.com, Hindustan Times, New Delhi
UPDATED ON JAN 22, 2021 08:52 PM IST
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.

'No angle ruled out yet': What we know so far on Serum Institute fire
Written by Poulomi Ghosh
UPDATED ON JAN 22, 2021 07:45 PM IST
United Nations Secretary-General Antonio Guterres expressed grief over the fire incident.

SII fire accident or sabotage to be known after probe, says Uddhav Thackeray
PTI
PUBLISHED ON JAN 22, 2021 06:15 PM IST
Five men died in the fire that broke out in a five- storeyed under-construction building in the SII's Manjari premises in Pune on Thursday.

Covishield: A timeline of the Covid-19 vaccine manufactured by SII
By hindustantimes.com | Written by Srivatsan K C
UPDATED ON JAN 16, 2021 11:21 PM IST
Pune-based Serum Institute of India partnered with the Oxford University to manufacture their Covishield vaccine in India.

Serum Institute’s Adar Poonawalla takes Covishield vaccine, congratulates PM
By HT Correspondent | Edited by Abhinav Sahay, Pune
PUBLISHED ON JAN 16, 2021 02:27 PM IST
- The SII also plans to export Covishield doses to Brazil in the coming days.

As vaccine trucks leave Serum campus, India starts fight to end Covid in country
By Shalaka Shinde, Steffy Thevar, Pune
UPDATED ON JAN 12, 2021 10:44 PM IST
At the stroke of 4:53 am, the gates opened, a police escort van remerged; it was followed by three trucks, with boxes carrying 5.65 million doses of the vaccine meant for Delhi, Chennai, Ahmedabad, Hyderabad, Chandigarh, Kolkata, Patna, Bengaluru, and Lucknow.

Serum Institute, Bharat Biotech pledge smooth Covid-19 vaccine roll-out
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 05:03 PM IST
Both the vaccine makers on Tuesday communicated their combined intent to develop, manufacture and supply Covid-19 vaccines

Exports of Covishield allowed to all countries, clarifies Adar Poonawalla
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 03:08 PM IST
Bharat Biotech and Serum Institute of India will issue a joint statement to clarify a few points as since Sunday the two vaccine makers appear to be at loggerheads.

Sparks fly over ‘water’: Covaxin hits out at critics, says trials 200% honest
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 05, 2021 05:34 AM IST
Experts pointed out that the government may have acted in haste, and the sentiment was echoed by some Opposition politicians who suggested that the Union government ignored scientific protocols to give the nod to a fully indigenous vaccine because it tied in with the Atmanirbhar Bharat slogan.

Covishield vaccine to be sold to govt at Rs 200/ dose, higher price for private buyers, says Adar Poonawalla
By Associated Press | Posted by Arpan Rai | New Delhi
UPDATED ON JAN 04, 2021 09:56 AM IST
With rich nations reserving most of the vaccines that will be made this year, Serum Institute — the world’s largest vaccine manufacturer — is likely to make most of the inoculations for developing countries.

‘Can deliver vaccines 7-10 days after purchase order’: Adar Poonawalla
By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON JAN 04, 2021 05:48 AM IST
“We wanted the drugs controller and the ministry of health to really go through all the data, examine everything, to double check what we have done, what Oxford has done that is safe and effective,” Adar Poonawalla, CEO of SII.

SII to meet local demand for Oxford vaccine for next 2 months, before exporting
By Reuters | Posted by Kanishka Sarkar | New Delhi
PUBLISHED ON JAN 03, 2021 09:13 PM IST
SII is still waiting to strike a formal supply deal with the government, but is expected to do so in the coming days.

‘Finally paid off’: Adar Poonawalla thanks PM Modi, DCGI after Covishield gets final approval
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON JAN 03, 2021 08:29 PM IST
Even before getting the approval from the apex drug controller of India, Serum Institute of India stockpiled about 40-50 million doses of the Covid-19 vaccine, taking a major risk.

Why India could catch up quickly on Covid vaccination
By HT Correspondent | Hindustan Times, New Delhi
UPDATED ON JAN 02, 2021 04:58 AM IST
With the manufacturing and stockpiling license, the Serum Institute of India has already been able to stockpile 75 million doses of the Oxford/AstraZeneca vaccine and by the first week of January, we will have 100 million doses.

Happy Vaccine Year
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON JAN 02, 2021 04:32 AM IST
An SII official said on Thursday at a webinar that the company had already stockpiled 75 million doses. SII’s chief executive Adar Poonawalla on Wednesday said the company will be supplying India and Covax in a 50-50 manner as and when it produces vials.

Nod for emergency use authorisation expected in a few days: SII’s Adar Poonawalla
By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON DEC 29, 2020 04:26 AM IST
The Pune-based vaccine maker’s CEO Adar Poonawalla said separately on Monday that approvals were expected in a few days,

‘300 million doses by July’: SII chief Adar Poonawalla on Covishield
By hindustantimes.com | Edited by Arpan Rai | Hindustan Times, New Delhi
UPDATED ON DEC 28, 2020 08:05 PM IST
Hinting at approval from British and Indian governments to approve shots for emergency use, Poonawalla said, “You will be hearing some good news from the UK very soon.”

Govt must protect vaccine makers against lawsuits: SII’s Adar Poonawalla
By hindustantimes.com | Edited by Meenakshi Ray | Hindustan Times, New Delhi
UPDATED ON DEC 19, 2020 10:29 AM IST
The government, Adar Poonawalla said, should bring a law as it would help companies focus on developing and manufacturing the vaccines rather than having to address legal issues.

Vaccination drive in India may start in January, says Adar Poonawalla as Serum Institute hopes to get nod by December
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON DEC 12, 2020 01:58 PM IST
Pune’s SII is preparing to manufacture enough vaccines for the government as well as private makers.